(Press-News.org) CHICAGO, IL (May 30, 2014)—Patients with AIDS-related lymphomas (ARL) may face an increased risk of central nervous system involvement (CNSi) compared to other lymphomas. The effect of CNSi on survival outcomes, however, hasn't been thoroughly examined until now.
In a new study led by Fox Chase Cancer Center Hematologist and Oncologist Stefan K. Barta, MD, MS, MRCP, researchers report that CNSi – identified at the time of an ARL diagnosis – does not appear to have an impact on overall survival. Dr. Barta's collaborators will present the findings at the 50th Annual Meeting of the American Society of Clinical Oncology.
In the same study, he and his team found that patients with CNSi at the time of diagnosis were nearly three times as likely, on average, to have CNS relapse (CNSr) during cancer treatment. CNSr is generally associated with particularly poor prognosis.
"It occurs early and usually has a poor outcome, though there are long term survivors," said Dr. Barta. He hopes a better understanding of how CNS involvement affects prognosis could lead to improvements in diagnostic tools and treatments.
Infection with human immunodeficiency virus, or HIV, greatly increases a person's risk of being diagnosed with many lymphomas. AIDS-related lymphomas (ARL), which include diffuse large cell lymphomas and small noncleaved cell lymphomas, are particularly aggressive forms of disease. The vast majority of patients—at least 80 percent, according to the National Cancer Institute—have stage IV disease at the time of presentation. The central nervous system is among the most common sites outside the lymph nodes that may be involved with ARL.
In 2013, as part of a study on factors that influence outcomes for patients with ARL, Dr. Barta led the assembly of a database containing medical data from more than 1500 patients newly diagnosed with AIDS-related lymphomas who participated in clinical trials in Europe and the United States between 1990 and 2010, inclusive.
In the new study, he and his colleagues used the same database to identify 880 patients with ARL whose data included complete information on central nervous system involvement (CNSi) at diagnosis and relapse (CNSr).
They analyzed data to identify associations between CNSr and a variety of patient characteristics, including age, sex, CD4 count, treatment history with cART, lymphoma subtype, rituximab use, and type of initial chemotherapy. Only CNSi conferred a higher risk of relapse.
CNSi was identified in 13 percent of all 880 patients at the time of diagnosis, including 27 percent of patients with Burkitt Lymphoma or Burkitt-like lymphoma and 6 percent in patients with diffuse large B-cell lymphoma. Dr. Barta and his colleagues found that 5.3 percent of patients experienced CNSr a median of 4.2 months after diagnosis; those patients had a median overall survival of 1.6 months.
Sixty-nine percent—607 patients—had been treated with combination anti-retroviral therapies, or cART. These therapies, which came into use in 1996, reversed the dismal survival rates for patients with full-blown AIDS and slowed the onset of AIDS for patients infected with HIV. However, Dr. Barta and his team found that cART did not reduce the frequency of CNSr in patients diagnosed with ARL. Neither did other treatments the patients had received, which included combination chemotherapies with or without rituximab—a monoclonal antibody that acts against B-cells.
"Over the last few years, people have realized that intrathecal CNS prophylaxis is probably inadequate, at least for diffuse large B-cell lymphomas, and many physicians have abandoned it," said Dr. Barta.
Dr. Barta, whose research focuses on ARL, said his findings suggest the approaches used to identify CNS involvement may be missing many patients who are at risk of CNS relapse, and current treatments are insufficient.
"A lot of patients who relapsed probably had undetected CNS involvement at diagnosis," he said. "We want to figure out if there are better strategies to identify patients at risk."
INFORMATION:
Barta's coauthors include Jitesh Joshi, Xiaonan Xue, Dan Wang, Joseph A. Sparano, Nicolas Mounier, Josep-Maria Rivera, Christopher Wyen, Kieron Dunleavy, Richard F. Little, Wyndham H. Wilson, and Ariela Noy.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center's nursing program has received the Magnet status for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, visit Fox Chase's Web site at http://www.foxchase.org or call 1-888-FOX CHASE or (1-888-369-2427). END
Identification of central nervous system involvement for patients with AIDS-related lymphomas
2014-05-30
ELSE PRESS RELEASES FROM THIS DATE:
Moffitt Cancer Center instrumental in new clinical guidelines for cancer-related fatigue
2014-05-30
TAMPA, Fla. (May 30, 2014) – Fatigue is a debilitating problem for cancer patients undergoing treatment; however, it also poses a huge detriment after treatment and can significantly affect quality of life. Approximately 30 percent of cancer patients endure persistent fatigue for several years after treatment, according to an American Society of Clinical Oncology Expert Panel co-chaired by Paul Jacobsen, Ph.D., associate center director of Population Sciences at Moffitt Cancer Center.
ASCO created the panel to develop assessment, screening, and treatment guidelines for ...
First real time movies of the light-to-current conversion in an organic solar cell
2014-05-30
VIDEO:
Real time quantum simulation of the conversion of light into current in an organic solar cell composed of a polymer chain, and a Fullerene buckyball. The movie lasts for about...
Click here for more information.
Photovoltaic cells directly convert sun light into electricity and hence are key technological devices to meet one of the challenges that mankind has to face in this century: a sustainable and clean production of renewable energy. Organic solar cells, using polymeric ...
Research details how developing neurons sense a chemical cue
2014-05-30
Symmetry is an inherent part of development. As an embryo, an organism's brain and spinal cord, like the rest of its body, organize themselves into left and right halves as they grow. But a certain set of nerve cells do something unusual: they cross from one side to the other. New research in mice delves into the details of the molecular interactions that help guide these neurons toward this anatomical boundary.
In an embryo, a neuron's branches, or axons, have special structures on their tips that sense chemical cues telling them where to grow. The new findings, by ...
Study highlights side effects felt by BRCA mutation carriers after cancer risk-reducing procedure
2014-05-30
PHILADELPHIA — The majority of women with cancer causing BRCA1 and BRCA2 mutations experience sexual dysfunction, menopausal symptoms, cognitive and stress issues, and poor sleep following prophylactic removal of their Fallopian tubes and ovaries - a procedure known as risk-reducing salpingo-oophorectomy (RRSO) - according to results of a new study from the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania. The team's findings, which reaffirm the need for a better understanding of how to manage long-term effects of the risk-reducing ...
Can narcissists be moved to show empathy?
2014-05-30
Researchers at the University of Surrey and the University of Southampton have investigated whether narcissists can elicit empathy for another person's suffering. It has been well documented that narcissists lack empathy, but why is that the case, and do they have the capacity to change that behavior? The research is published in Personality and Social Psychology Bulletin.
Characterizing narcissism
When we think of narcissism most of us can all think of a colleague, friend, or former significant other that would fit the description; "A bit full of themselves, self-centered, ...
Narcissists can feel empathy, research finds
2014-05-30
Narcissists tend to lack empathy, which can cause problems for themselves, the people around them and society in general. However, new research published today from the University of Surrey, suggests that with the right focus, people with narcissistic tendencies can feel empathy for another person's suffering. This may be important in helping to prevent the often violent or anti-social behaviours that some narcissists are prone to and the crimes that are committed as a result.
The research, published in Personality and Social Psychology Bulletin, studied participants ...
Eating prunes can help weight loss
2014-05-30
Research by the University of Liverpool has found that eating prunes as part of a weight control diet can improve weight loss.
Consumption of dried fruit is not readily recommended during weight loss despite evidence it enhances feelings of fullness.
However, a study by the University's Institute of Psychology, Health and Society of 100 overweight and obese low fibre consumers tested whether eating prunes as part of a weight loss diet helped or hindered weight control over a 12-week period.
It also examined if low fibre consumers could tolerate eating substantial ...
Cochrane review on use of rectal artesunate for severe malaria
2014-05-30
Researchers from the Cochrane Infectious Diseases Group, hosted at LSTM, conducted an independent review of the effects of pre-referral rectal artesunate for people with severe malaria, published in the Cochrane Library today. The review follows a large trial of rectal artesunate in 2009 which led the World Health Organization to recommend its use.
Severe malaria is a serious medical condition caused by infection with the Plasmodium parasite. It is treated by giving injections of antimalarial drugs, which need to be started as quickly as possible to reduce the risk of ...
One cell's meat is another cell's poison
2014-05-30
As a new therapeutic approach, Janus kinases are currently in the limelight of cancer research. The focus of interest is the protein JAK2. By inhibiting this protein one tries to cure chronic bone marrow diseases, such as myelofibrosis and chronic myeloid leukemia (CML).
Loss of JAK2 is advantageous for leukemia cells
Scientists working with Veronika Sexl at the Institute of Pharmacology and Toxicology may initiate a transformation of thought in regard of JAK2 inhibition. To simulate the human disease as accurately as possible, the scientists used a mouse leukemia ...
Chinese scientists map reproductive system's evolution as dinosaurs gave rise to birds
2014-05-30
As winged dinosaurs underwent a series of evolutionary changes during the transition into Aves, or birds, one pivotal transformation was the appearance of a single-ovary reproductive system. "The most widely accepted hypothesis for the presence of a single functional ovary in living birds is that the right ovary … was lost to reduce body mass in gravid females during flight," report a team of Chinese scientists who are adding new details to the mosaic of understanding how terrestrial dinosaurs gave rise to birds and powered flight.
These scientists, led by the director ...